Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients

Christoph Röllig, Ulrich S. Schuler, Maria Gabrecht et al.|Annals of Oncology|2018

Cited by 37